We've moved!
Please visit us at our new Learning management system at https://education.ipecamericas.org/courses and/or contact us at ipecamer@ipecamericas.org.
On-Demand
Recorded versions of (past) live webinars are available for purchase. Presentations on topics critical to manufacturers and users of pharmaceutical excipients. These will be available in about one week.
The IPEC Validation Guide for Pharmaceutical Excipients issued in January 2021.
Join us for a comprehensive overview of Excipient World 2021… and walk away with a clear understanding of why you should attend!
The growth in biologic drug development has been dramatic in the last 10 years and is set to continue in the future.
There is increasing awareness of the important role that excipient functionality plays in drug formulations, both in existing and in new formulations.
There have been some major advances over the last 20 years in the use of polymeric excipients for film coating in solid oral dosages.
This webinar included a 2 hours of interactive presentations. We invited academic, industry, and regulatory experts to provide different perspectives.
The European Chemicals Agency (ECHA) is moving forward with proposed restrictions on the use of microplastics in products used in various market segments.
Do excipient unknowns derail your drug development project? What you don’t know about your excipients might surprise you, and could impact your product.
Most on-site audits of excipient suppliers have been suspended (deferred) due to the pandemic; however, on-going supplier assessments are still required.
The presenters provided an overview of the soon-to-be-published IPEC GMP Certification Scheme and Certification Body Qualification Guide for Pharmaceutical Excipients.
This Webinar provided an overview of current excipient related regulations in India for the domestic and export markets along with a preview of some potential emerging challenges.
In this presentation, FDA has identify all the changes that have occurred in preparation for fulfilling our GDUFA II commitments for the IID and changes yet to come in 2020.
Discussed why chemical ingredient distributors are an essential segment of the supply chain - providing excipients to developers and manufacturers of drug products.
This webinar is a first-hand account of the challenges to realizing, determining, and confirming the novel status of an inactive ingredient in a Phase III Clinical drug product.
Dr. Hartung discussed revolutionary changes in how we predict human safety by assessing biological effects of chemicals in novel ways.
IPEC-Americas members have been busy while quarantined, and several new guides and position papers have been finalized.
This webinar was designed to help participants understand the underlying science behind the unpredictable in vivo performance of enteric coated formulations.
This webinar focused on current and emerging CFDA regulatory activities in China related to the use and approval of excipients.
This webinar provided a high-level overview of continuous manufacturing including efforts and status for ICH Q13 Continuous Manufacturing of Drug Substances and Drug Products Guideline.
Nitrosamines and related compounds are a hot topic among regulatory agencies in the U.S., Europe, Canada, Brazil and elsewhere.
The new joint PDA IPEC risk assessment for excipients technical report has recently been published.
This webinar addressed the impact of multi-sourcing of excipients on the manufacture, quality, safety, and efficacy of drug products.
The presenter discussed what a pharmaceutical company should do when their excipient supplier won’t allow an on-site audit.
Review of the regulations and guidelines which apply to pharmaceutical excipient use in primary Latin American countries (e.g. Brazil, Argentina, MERCOSUR, Andes, Mexico).
Elemental Impurities: Filing experiences and the FDA
This webcast provides an overview of microplastics and highlights issues that both users and makers can consider when submitting individual company responses to ECHA.
The webinar introduces the United States Pharmacopeia (USP) and their standards and programs.
Webinar recording from March 27, 2019. The new topic will address regulatory practices regarding inactive ingredients used in cosmetics, food, dietary supplements and pharmaceuticals.
This webinar will survey the recent regulatory findings concerning data integrity.
This webinar reviewed the issues surrounding technically unavoidable particles (TUP) and explain how the TUPPs guide can be used for evaluating visible particles in excipients.
The DMF Guide Overview - the main focus of the Guide is for U.S. Type IV (excipient) DMF content, format, filing, and review.
Ralph Lindblad presents: Auditing to Monitor the Excipient Manufacturer; Partnering for success; building relationships with the supplier and excipient assessors.
Review of IPEC-Americas most recently updated Significant Change guide.
This webcast will discuss the importance of additives, impurities and concomitant components to excipient function.
This webcast is an overview of the IPEC guide Quality Agreement Guide and Template(s) for Pharmaceutical Excipients 2017
This webcast is an overview of the IPEC guide Qualification of Excipients for use in Pharmaceuticals.
This webinar will provide excipient users with specific, practical advice on the implementation of elemental impurities requirements for finished dosage forms.
This webinar presented an overview of nanotechnology - what is it, why is it important, and examples of its current use in the pharmaceutical and other industries.
